ACI’s 4th Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA – October 8-24, 2024 (Virtual)
August 28, 2024The American Conference Institute (“ACI”) will hold (virtually) its 4th Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA from October 8-24, 2024. This virtual three-week program is designed to give new lawyers and executives a solid foundation in the essentials and intricacies of Hatch-Waxman and BPCIA litigation and regulation.
Gain a comprehensive understanding of Hatch-Waxman and BPCIA essentials—critical competencies for legal and business professionals in the biopharmaceutical sector. Everyone in the life sciences industry must be well-versed in the regulatory components and intellectual property nuances integral to patenting products.
This year’s co-chairs include Fangli Chen, Ph.D. (Partner, Proskauer Rose LLP) and Jason Murata (Partner, Axinn, Veltrop & Harkrider). Hyman, Phelps & McNamara, P.C. Director Sara W. Koblitz will speak during Module 5 on various Hatch-Waxman and BPCIA topics. The series, held virtually on Tuesday and Thursday afternoons on ACI’s interactive platform, will provide an in-depth review of Hatch-Waxman and the BPCIA, as well as other intellectual property basics related to small molecules and biologics. This program lays the groundwork for understanding the patent life cycles of biopharmaceutical products and business development plans.
To learn more about the program and to view the agenda, see here. FDA Law Blog readers receive a 10% discount (use FDA Law Blog promo code: D10-999-FDA25).